Cefepime-Aztreonam: a Unique Double β-Lactam Combination for Pseudomonas aeruginosa

An in vitro pharmacokinetic model was used to determine if aztreonam could enhance the pharmacodynamics of cefepime or ceftazidime against an isogenic panel of Pseudomonas aeruginosa 164, including wild-type (WT), partially derepressed (PD), and fully derepressed (FD) phenotypes. Logarithmic-phase c...

Descripción completa

Detalles Bibliográficos

Publicado en:	Antimicrob Agents Chemother
Autores principales:	Lister, Philip D., Sanders, W. Eugene, Sanders, Christine C.
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	American Society for Microbiology (ASM) 1998
Materias:	Experimental Therapeutics
Acceso en línea:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC105655/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9660993/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.42.7.1610
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!